Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China · Delayed Price · Currency is CNY 2.690
+0.090 (3.46%)
At close: Jan 23, 2026
SHA:603077 Revenue
Sichuan Hebang Biotechnology Corporation had revenue of 2.01B CNY in the quarter ending September 30, 2025, with 2.05% growth. This brings the company's revenue in the last twelve months to 7.66B, down -16.77% year-over-year. In the year 2024, Sichuan Hebang Biotechnology Corporation had annual revenue of 8.55B, down -3.13%.
Revenue (ttm)
7.66B
Revenue Growth
-16.77%
P/S Ratio
2.80
Revenue / Employee
1.42M
Employees
5,386
Market Cap
21.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.55B | -276.63M | -3.13% |
| Dec 31, 2023 | 8.82B | -4.21B | -32.33% |
| Dec 31, 2022 | 13.04B | 3.05B | 30.55% |
| Dec 31, 2021 | 9.99B | 4.73B | 89.85% |
| Dec 31, 2020 | 5.26B | -708.33M | -11.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Huayi Group Corporation | 42.76B |
| Jinan Shengquan Group Share Holding | 10.94B |
| Sichuan Development Lomon | 9.51B |
| Shanghai Pret Composites | 9.36B |
| Guizhou Chanhen Chemical | 7.74B |
| Tinergy Chemical | 7.49B |
| Shenzhen Senior Technology Material | 3.89B |
| Sichuan New Energy Power Company | 2.87B |